{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:08:21Z","timestamp":1789513701969,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12072-025-11029-5","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T16:50:33Z","timestamp":1771087833000},"page":"408-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors of adult recipient survival beyond 20\u00a0years since liver transplantation: retrospective cohort study"],"prefix":"10.1007","volume":"20","author":[{"given":"Carlos","family":"Jim\u00e9nez-Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Vivas-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Marcacuzco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Bernaldo de Quiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0553-5835","authenticated-orcid":false,"given":"Iago","family":"Justo-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"11029_CR1","first-page":"659","volume":"117","author":"TE Starzl","year":"1963","unstructured":"Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963;117:659\u2013676","journal-title":"Surg Gynecol Obstet"},{"key":"11029_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/SLA.0b013e3182a15db4","volume":"258","author":"VG Agopian","year":"2013","unstructured":"Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, et al. The evolution of liver transplantation during 3 decades. Analysis of 5347 consecutive liver transplants at a single center. Ann Surg 2013;258:409\u2013421. https:\/\/doi.org\/10.1097\/SLA.0b013e3182a15db4","journal-title":"Ann Surg"},{"key":"11029_CR3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/tri.13358","volume":"31","author":"R Adam","year":"2018","unstructured":"Adam R, Karam V, Cailliez V, O Grady JG, Mirza D, Cherqui D, et al. Annual Report of the European Liver Transplantation Registry (ELTR)-50-year evolution of liver transplantation. Transpl Int 2018;31:1293\u20131317. https:\/\/doi.org\/10.1111\/tri.13358","journal-title":"Transpl Int"},{"key":"11029_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/TP.0000000000002147","volume":"102","author":"M Charlton","year":"2018","unstructured":"Charlton M, Levitsky J, Aqel B, O\u2019Grady J, Hemibach J, Rinella M, et al. International liver transplantation society consensus statement on immunosuppression in liver transplant recipients. Transplantation 2018;102:727\u2013743. https:\/\/doi.org\/10.1097\/TP.0000000000002147","journal-title":"Transplantation"},{"issue":"Suppl. 1","key":"11029_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/liv.13651","volume":"38","author":"F Durand","year":"2018","unstructured":"Durand F. How to improve long-term outcome after liver transplantation? Liver Int 2018;38(Suppl. 1):134\u2013138. https:\/\/doi.org\/10.1111\/liv.13651","journal-title":"Liver Int"},{"key":"11029_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.jceh.2022.03.012","volume":"12","author":"J Neuberger","year":"2022","unstructured":"Neuberger J. Long-term care of the adult liver transplant recipient. J Clin Exp Hepatol 2022;12:1547\u20131556. https:\/\/doi.org\/10.1016\/j.jceh.2022.03.012","journal-title":"J Clin Exp Hepatol"},{"key":"11029_CR7","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1111\/ajt.12384","volume":"13","author":"WN Schoening","year":"2013","unstructured":"Schoening WN, Buescher N, Rademacher S, Andreou A, Kuehn S, Neuhaus R, et al. Twenty-year longitudinal follow-up after orthotopic liver transplantation: a single-center experience of 313 consecutive cases. Am J Transplant 2013;13:2384\u20132394. https:\/\/doi.org\/10.1111\/ajt.12384","journal-title":"Am J Transplant"},{"key":"11029_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12072-014-9577-x","volume":"9","author":"C Dopazo","year":"2015","unstructured":"Dopazo C, Bilbao I, Castells L, Sapisochin G, Moreiras C, Campos-Varela I, et al. Analysis of adult 20-year survivors after liver transplantation. Hepatol Int 2015;9:461\u2013470. https:\/\/doi.org\/10.1007\/s12072-014-9577-x","journal-title":"Hepatol Int"},{"key":"11029_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13041087","volume":"13","author":"P De Simone","year":"2024","unstructured":"De Simone P, Bronzoni J, Martinelli C, Ducci J, Campani D, Gitto S, et al. Aging with a liver graft: analysis of very long-term survivors after liver transplantation. J Clin Med 2024;13:1087. https:\/\/doi.org\/10.3390\/jcm13041087","journal-title":"J Clin Med"},{"key":"11029_CR10","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/TP.0b013e3182129215","volume":"91","author":"A Jain","year":"2011","unstructured":"Jain A, Singhal A, Fontes P, Mazariegos G, de Vera ME, Cacciarelli T, et al. One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17-to 20-year longitudinal follow-up. Transplantation 2011;91:1025\u20131030. https:\/\/doi.org\/10.1097\/TP.0b013e3182129215","journal-title":"Transplantation"},{"key":"11029_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.105981","volume":"91","author":"C Jim\u00e9nez-Romero","year":"2021","unstructured":"Jim\u00e9nez-Romero C, Justo I, Marcacuzco A, Garc\u00eda V, Manrique A, Garc\u00eda-Sesma A, et al. Safe use of livers from deceased donors older than 70\u00a0years in recipients with HCV cirrhosis treated with direct-action antivirals. Retrospective cohort study. Int J Surg 2021;91:105981. https:\/\/doi.org\/10.1016\/j.ijsu.2021.105981","journal-title":"Int J Surg"},{"issue":"2 Suppl 1","key":"11029_CR12","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.ajt.2023.02.006","volume":"23","author":"AJ Kwong","year":"2023","unstructured":"Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP, et al. OPTN\/SRTR 2021 annual data report: liver. Am J Transplant 2023;23(2 Suppl 1):S178\u2013S263. https:\/\/doi.org\/10.1016\/j.ajt.2023.02.006","journal-title":"Am J Transplant"},{"key":"11029_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/SLA.0b013e3181f5f23a","volume":"252","author":"JP Duffy","year":"2010","unstructured":"Duffy JP, Kao K, Ko CY, Farmer G, McDiarmid SV, Hong JC, et al. Long-term patient outcome and quality of life after liver transplantation. Analysis of 20-year survivors. Ann Surg 2010;252:652\u2013661. https:\/\/doi.org\/10.1097\/SLA.0b013e3181f5f23a","journal-title":"Ann Surg"},{"key":"11029_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/lt.25646","volume":"26","author":"C Jim\u00e9nez-Romero","year":"2020","unstructured":"Jim\u00e9nez-Romero C, Manrique A, Garc\u00eda-Conde M, Nutu A, Calvo J, Caso O, et al. Biliary complications after liver transplantation from uncontrolled donors after circulatory death: incidence, management and outcome. Liver Transpl 2020;26:80\u201391. https:\/\/doi.org\/10.1002\/lt.25646","journal-title":"Liver Transpl"},{"key":"11029_CR15","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s13304-023-01598-1","volume":"75","author":"Q Lai","year":"2023","unstructured":"Lai Q, Mennini G, Corradini SG, Ferri F, Fonte S, Pugliese F, et al. Adult 10-year survivors after liver transplantation: a single institution experience over 40\u00a0years. Updates Surg 2023;75:1961\u20131970. https:\/\/doi.org\/10.1007\/s13304-023-01598-1","journal-title":"Updates Surg"},{"key":"11029_CR16","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","volume":"10","author":"D Collet","year":"2010","unstructured":"Collet D, Mumford L, Banner NR, Neuberger J, Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit. Am J Transplant 2010;10:1889\u20131896. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03181.x","journal-title":"Am J Transplant"},{"key":"11029_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/145749691110000104","volume":"100","author":"E Aberg","year":"2011","unstructured":"Aberg E, Isoniem H, Hockerstedt K. Long-term results of liver transplantation. Scand J Surg 2011;100:14\u201321. https:\/\/doi.org\/10.1177\/145749691110000104","journal-title":"Scand J Surg"},{"key":"11029_CR18","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","volume":"306","author":"EA Engells","year":"2011","unstructured":"Engells EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306:1891\u20131901. https:\/\/doi.org\/10.1001\/jama.2011.1592","journal-title":"JAMA"},{"key":"11029_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/(sici)1097-0142(19970915)80:6<1141::aid-cncr18>3.0.co;2-8","volume":"80","author":"S Jonas","year":"1997","unstructured":"Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, Guckelberger O, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor or antithymocyte globulin. Cancer 1997;80:1141\u20131150. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19970915)80:6%3c1141::aid-cncr18%3e3.0.co;2-8","journal-title":"Cancer"},{"key":"11029_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0002-9610(98)00141-x","volume":"176","author":"R Fabia","year":"1998","unstructured":"Fabia R, Levy MF, Testa G, Obiekwe S, Goldstein RM, Husberg BS, et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 1998;176:265\u2013269. https:\/\/doi.org\/10.1016\/s0002-9610(98)00141-x","journal-title":"Am J Surg"},{"key":"11029_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/s0168-8278(00)00077-5","volume":"34","author":"EB Haagsma","year":"2001","unstructured":"Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, et al. Increased cancer risk after liver transplantation: a population based-study. J Hepatol 2001;34:84\u201391. https:\/\/doi.org\/10.1016\/s0168-8278(00)00077-5","journal-title":"J Hepatol"},{"key":"11029_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1053\/jlts.2002.35551","volume":"8","author":"AB Mithoefer","year":"2002","unstructured":"Mithoefer AB, Supran S, Freeman RB. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl 2002;8:939\u2013944. https:\/\/doi.org\/10.1053\/jlts.2002.35551","journal-title":"Liver Transpl"},{"key":"11029_CR23","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1053\/j.gastro.2009.08.070","volume":"137","author":"KD Watt","year":"2009","unstructured":"Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Sanchez W, Gores GJ. Long-term probability of and mortality from the novo malignancy after liver transplantation. Gastroenterology 2009;137:2010\u20132017. https:\/\/doi.org\/10.1053\/j.gastro.2009.08.070","journal-title":"Gastroenterology"},{"key":"11029_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jhep.2005.10.007","volume":"44","author":"W Sanchez","year":"2006","unstructured":"Sanchez W, Talwalkar JA, Gores GJ. Will all liver transplantation patients eventually die from cancer? J Hepatol 2006;44:13\u201318. https:\/\/doi.org\/10.1016\/j.jhep.2005.10.007","journal-title":"J Hepatol"},{"key":"11029_CR25","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1111\/liv.12758","volume":"35","author":"C Carenco","year":"2015","unstructured":"Carenco C, Faure S, Herrero A, Assenat E, Duny Y, Danan G, et al. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidences rates and risk factors. Liver Int 2015;35:1748\u20131755. https:\/\/doi.org\/10.1111\/liv.12758","journal-title":"Liver Int"},{"key":"11029_CR26","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4254\/wjh.v7.i7.942","volume":"7","author":"C Jim\u00e9nez-Romero","year":"2015","unstructured":"Jim\u00e9nez-Romero C, Justo-Alonso I, Cambra-Molero F, Calvo-Pulido F, Garc\u00eda-Sesma A, Abradelo de Usera M, et al. Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis. World J Hepatol 2015;7:942\u2013953. https:\/\/doi.org\/10.4254\/wjh.v7.i7.942","journal-title":"World J Hepatol"},{"key":"11029_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/00007890-200108270-00010","volume":"72","author":"CO Bellamy","year":"2001","unstructured":"Bellamy CO, DiMartini AM, Ruppert K, Jain A, Dodson F, Torbenson M, et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001;72:619\u2013626. https:\/\/doi.org\/10.1097\/00007890-200108270-00010","journal-title":"Transplantation"},{"key":"11029_CR28","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.transproceed.2006.08.065","volume":"38","author":"C Jim\u00e9nez-Romero","year":"2006","unstructured":"Jim\u00e9nez-Romero C, Manrique-Municio A, Marqu\u00e9s-Medina E, Colina F, Ortega Domene P, G\u00f3mez-Sana R, et al. Incidence of nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases. Transplant Proc 2006;38:2505\u20132507. https:\/\/doi.org\/10.1016\/j.transproceed.2006.08.065","journal-title":"Transplant Proc"},{"key":"11029_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/lt.22064","volume":"16","author":"AS Tjon","year":"2010","unstructured":"Tjon AS, Sint Nicolaas J, Kwekkeboom J, de Man RA, Kazemier G, Tilanus HW, et al. Comparison of the incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age. Liver Transpl 2010;16:837\u2013846. https:\/\/doi.org\/10.1002\/lt.22064","journal-title":"Liver Transpl"},{"key":"11029_CR30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","volume":"57","author":"R Adam","year":"2012","unstructured":"Adam R, Karam V, Delvart V, O\u2019Grady J, Mirza D, Klempnauer J, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012;57:675\u2013688. https:\/\/doi.org\/10.1016\/j.jhep.2012.04.015","journal-title":"J Hepatol"},{"key":"11029_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/LVT.0000000000000244","volume":"30","author":"N Palaniyappan","year":"2024","unstructured":"Palaniyappan N, Peach E, Pearce F, Dhaliwal A, Campos-Varela I, Cant MR, et al. Long-term outcomes (beyond 5\u00a0years) of liver transplant recipients\u2014a transatlantic multicenter study. Liver Transplant 2024;30:170\u2013181. https:\/\/doi.org\/10.1097\/LVT.0000000000000244","journal-title":"Liver Transplant"},{"key":"11029_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12906","volume":"31","author":"KE Daniel","year":"2017","unstructured":"Daniel KE, Eickhoff J, Lucey MR. Why do patients die after a liver transplantation. Clin Transplant 2017;31:e12906. https:\/\/doi.org\/10.1111\/ctr.12906","journal-title":"Clin Transplant"},{"key":"11029_CR33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMoa021744","volume":"349","author":"AO Ojo","year":"2003","unstructured":"Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931\u2013940. https:\/\/doi.org\/10.1056\/NEJMoa021744","journal-title":"N Engl J Med"},{"key":"11029_CR34","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/ajt.14212","volume":"17","author":"F Saliba","year":"2017","unstructured":"Saliba F, Duvoux C, Guhenheim J, Kamar N, Dharancy S, Salam\u00e9 E, et al. Efficacy and safety of everolimus and mycophenolic acid with early tacrolimus withdrawal after liver transplantation: a multicenter randomized trial. Am J Transplant 2017;17:1843\u20131852. https:\/\/doi.org\/10.1111\/ajt.14212","journal-title":"Am J Transplant"},{"key":"11029_CR35","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/lt.21170","volume":"13","author":"C Creput","year":"2007","unstructured":"Creput C, Blandin F, Deroure B, Roche B, Saliba F, Charpentier B, et al. Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation. Liver Transplant 2007;13:1004\u20131010. https:\/\/doi.org\/10.1002\/lt.21170","journal-title":"Liver Transplant"},{"key":"11029_CR36","doi-asserted-by":"publisher","first-page":"E639","DOI":"10.1111\/j.1399-0012.2011.01512.x","volume":"25","author":"M Kriss","year":"2011","unstructured":"Kriss M, Sotil EU, Abecassis M, Welti M, Levitsky J. Mycophenolate mofetil monotherapy in liver transplant recipients. Clin Transplant 2011;25:E639\u2013E646. https:\/\/doi.org\/10.1111\/j.1399-0012.2011.01512.x","journal-title":"Clin Transplant"},{"key":"11029_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2025.13790","volume":"38","author":"C Jim\u00e9nez-Romero","year":"2025","unstructured":"Jim\u00e9nez-Romero C, Justo Alonso I, Caso Maestro O, Manrique Municio A, Garc\u00eda-Sesma A, Calvo Pulido J, et al. Indications and long-term outcomes of using mycophenolate mofetil monotherapy in substitution for calcineurin inhibitors in liver transplantation. Transpl Int 2025;38:13790. https:\/\/doi.org\/10.3389\/ti.2025.13790","journal-title":"Transpl Int"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-11029-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-11029-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-11029-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T18:29:27Z","timestamp":1777314567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-11029-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["11029"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-11029-5","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Carlos Jim\u00e9nez-Romero, Alfredo Vivas L\u00f3pez, Alberto Marcacuzco, Oscar Caso, Mercedes Bernaldo de Quir\u00f3s and Iago Justo Alonso have no relevant or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No AI has been used to produce this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI statement"}}]}}